A higher-titer ANA raises the suspicion that something more systemic may be going on,’ said Amanda Mixon, PA-C.

Long-awaited updates to the American College of Rheumatology's (ACR) guideline on systemic lupus erythematosus (SLE) ...

Belimumab is linked to a reduced risk for all-cause mortality compared with azathioprine, methotrexate, and mycophenolate among patients with nonrenal SLE.

Because lupus can cause a lot of different health problems, there are many different kinds of medicines that can treat it. You and your doctors can work together to find the right combination of ...

Brussels, Belgium - Long-term follow-up of patients from the Euro-Lupus Nephritis Trial shows that induction with the low-dose IV cyclophosphamide (CYC) regimen used in that study, followed by ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Patients with non-renal systemic lupus erythematosus who receive belimumab demonstrate a lower ...

For most patients with active LN, six months of modern effective therapy will improve markers of disease activity, including anti-DNA antibody levels, serum complement, GFR, and degree of hematuria ...

Please provide your email address to receive an email when new articles are posted on . Silva and colleagues noted that studies have investigated treatment adherence in systemic lupus erythematosus.